Legal Representation
Attorney
Scott D. Woldow
USPTO Deadlines
Next Deadline
160 days remaining
NOA E-Mailed - SOU Required
Due Date
May 27, 2026
Extension Available
Until November 27, 2026
Application History
18 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Oct 27, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Oct 27, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Oct 27, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Oct 27, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| May 27, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Apr 1, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Apr 1, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 26, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Mar 6, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Mar 5, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Mar 5, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Mar 5, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 11, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 11, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 11, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 7, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 19, 2024 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 19, 2024 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 035
Promoting public awareness of blood conditions, diseases, disorders, and treatment; promoting the interests of patients with blood disorders by means of public advocacy, including through social media and events organized by others; promoting public awareness of the need for influenza immunization and vaccination programs; Business research in the field of public policy concerning policy initiatives for blood conditions and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals; promoting the donation of blood and plasma by means of arranging and conducting incentive reward programs; providing public policy information in the field of blood conditions and blood related diseases, its treatment and its impact on patients, patient families, caregivers and/or healthcare professionals.
Class 044
Providing medical information concerning blood products for humans, especially blood proteins for therapeutic use, blood clotting agents and antihemophilic factors, fibrinogen concentrate, and pharmaceutical preparations for the treatment of blood or bleeding disorders and deficiencies of blood coagulation; providing medical information and treatment information in the field of health; medical services, namely, providing medical information concerning blood products, providing medical information concerning health products and services; health care, namely, providing health care information in person, via the internet, and through the distribution of printed matter
Classification
International Classes
035
044